| pubmed-article:11824324 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11824324 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:11824324 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:11824324 | lifeskim:mentions | umls-concept:C0007121 | lld:lifeskim |
| pubmed-article:11824324 | lifeskim:mentions | umls-concept:C0441771 | lld:lifeskim |
| pubmed-article:11824324 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
| pubmed-article:11824324 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
| pubmed-article:11824324 | pubmed:dateCreated | 2002-2-4 | lld:pubmed |
| pubmed-article:11824324 | pubmed:abstractText | Patients with unfavorable stages of lung cancer are rarely cured with local treatment modalities alone. Aim of our phase II trial was to investigate the effectivity of a multimodality treatment. Ninety-four patients with NSCLC (stage IIIA/IIIB) were treated preoperatively with chemoradiotherapy (cisplatin and etoposide, 45 Gy hyperfractionated accelerated radiotherapy). After repeat mediastinoscopy patients underwent surgery. Complete resection (R0) was achieved in 53% of all patients with NSCLC. Two patients died of sepsis preoperatively and four postoperatively (90-days lethality: 6.4%). The median survival time was 20 months for IIIA and 18 months for IIIB. Calculated survival rates at 6 years were 34% for IIIA and 17% for IIIB. This multimodality treatment demonstrates high efficacy in prognostically unfavorable NSCLC compared with historical controls. | lld:pubmed |
| pubmed-article:11824324 | pubmed:language | ger | lld:pubmed |
| pubmed-article:11824324 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11824324 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11824324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11824324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11824324 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11824324 | pubmed:issn | 1868-1050 | lld:pubmed |
| pubmed-article:11824324 | pubmed:author | pubmed-author:MüllerM RMR | lld:pubmed |
| pubmed-article:11824324 | pubmed:author | pubmed-author:EberhardtWW | lld:pubmed |
| pubmed-article:11824324 | pubmed:author | pubmed-author:StamatisGG | lld:pubmed |
| pubmed-article:11824324 | pubmed:author | pubmed-author:StübenGG | lld:pubmed |
| pubmed-article:11824324 | pubmed:author | pubmed-author:HillejanLL | lld:pubmed |
| pubmed-article:11824324 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:11824324 | pubmed:volume | 118 | lld:pubmed |
| pubmed-article:11824324 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11824324 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11824324 | pubmed:pagination | 601-5 | lld:pubmed |
| pubmed-article:11824324 | pubmed:dateRevised | 2007-4-24 | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:meshHeading | pubmed-meshheading:11824324... | lld:pubmed |
| pubmed-article:11824324 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11824324 | pubmed:articleTitle | [Neoadjuvant chemotherapy and chemoradiotherapy in surgically treated non-small-cell stage III bronchial carcinoma]. | lld:pubmed |
| pubmed-article:11824324 | pubmed:affiliation | Ruhrlandklinik Essen, Tüschenerweg 40, 45239 Essen. | lld:pubmed |
| pubmed-article:11824324 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11824324 | pubmed:publicationType | English Abstract | lld:pubmed |
